Thomas Wright, DO
Obstetrics & Gynecology · Grand Blanc, MINPI 1184631657
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 37.3% of the total. Reporting peaked in 2022 at $453 and has fallen 83.3% since, to $76 in 2025.
Across 84 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$544
- Pfizer$162
- Sumitomo Pharma America, Inc.$128
- Myovant Sciences Inc.$121
- Hologic Sales And Service, LLC$109
- Organon$59
- plus $337 from 13 others
Across 26 payments — averaging $2702.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$70K
What the payments were for
- Food & beverage$1,44099%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $544 |
| Pfizer | 9 | $162 |
| Sumitomo Pharma America, Inc. | 6 | $128 |
| Myovant Sciences Inc. | 10 | $121 |
| Hologic Sales And Service, LLC | 5 | $109 |
| Organon | 2 | $59 |
| Aspira Women's Health Inc | 1 | $52 |
| Medtronic(2 entities) | 3 | $51 |
| Coloplast | 2 | $41 |
| Therapeuticsmd, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $28 |
| Smith+Nephew | 1 | $25 |
| Agile Therapeutics, Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $20 |
| Minerva Surgical, Inc | 1 | $18 |
| Bayer | 1 | $16 |
| Coopersurgical, Inc. | 1 | $16 |
| BD | 1 | $12 |
| Mayne Pharma Commercial LLC | 1 | $5 |
How this compares
$1,460 in reported general payments places this provider in the 70th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 19 | $1,405 |
| Estradiol | 13 | $422 |
| Metronidazole | 11 | $208 |
| Fluconazole | 14 | $65 |
| Misoprostol | 11 | $18 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Grand Blanc
- Julianna FriesenGrand Blanc$18K
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Jay FisherWest Bloomfield$136K
- Barbara DepreeZeeland$118K
- Rabbie HannaDetroit$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.